KOBLET; Andreas
Patent Applications and Registrations
Patent applications and USPTO patent grants for KOBLET; Andreas.The latest application filed is for "benzodiazepine derivatives as gaba a gamma1 pam".
- KOBLET; Andreas - Basel CH
- Koblet; Andreas - Bottmingen CH
- Koblet; Andreas - Binningen CH
| Patent | Date |
|---|---|
| Benzodiazepine Derivatives As Gaba A Gamma1 Pam App 20210309664 - CECERE; Giuseppe ; et al. | 2021-10-07 |
| Isoxazolyl ether derivatives as GABA.sub.A .alpha.5 PAM Grant 11,091,471 - Buettelmann , et al. August 17, 2 | 2021-08-17 |
| New Isoxazolyl Ether Derivatives As Gaba A Alpha5 Pam App 20210094945 - Cecere; Giuseppe ; et al. | 2021-04-01 |
| Isoxazolyl Ether Derivatives As Gaba A Alpha5 Pam App 20190300516 - BUETTELMANN; Bernd ; et al. | 2019-10-03 |
| Pyrrolidine compounds Grant 9,346,786 - Knust , et al. May 24, 2 | 2016-05-24 |
| Pyrrolidine derivatives Grant 9,226,916 - Knust , et al. January 5, 2 | 2016-01-05 |
| Imidazo[2,1]thiazol-3-one derivatives App 20150157739 - Gobbi; Luca ; et al. | 2015-06-11 |
| Pyrrolidine Compounds App 20130203728 - Knust; Henner ; et al. | 2013-08-08 |
| Pyrrolidine Derivatives App 20130184249 - Knust; Henner ; et al. | 2013-07-18 |
| Dual NK1/NK3 receptor antagonists Grant 8,404,708 - Hoffmann , et al. March 26, 2 | 2013-03-26 |
| Pyrrolidine derivatives as NK2 receptor antagonists Grant 8,404,679 - Bissantz , et al. March 26, 2 | 2013-03-26 |
| Pyrrolidine Derivatives As Nk2 Receptor Antagonists App 20120208803 - Bissantz; Caterina ; et al. | 2012-08-16 |
| Dual Nk1/nk3 Receptor Antagonists App 20110178055 - Hoffmann; Torsten ; et al. | 2011-07-21 |
| Pyrrolidine Compounds App 20110152233 - Knust; Henner ; et al. | 2011-06-23 |
| Pyrrolidine Derivatives App 20110144081 - Knust; Henner ; et al. | 2011-06-16 |
| Aryl-isoxazolo-4-yl-oxadiazole derivatives Grant 7,956,074 - Buettelmann , et al. June 7, 2 | 2011-06-07 |
| Dual NK1/NK3 receptor antagonists Grant 7,939,533 - Hoffmann , et al. May 10, 2 | 2011-05-10 |
| Pyrrolidine Derivatives As Nk2 Receptor Antagonists App 20090312327 - Bissantz; Caterina ; et al. | 2009-12-17 |
| Aryl-isoxazolo-4-yl-oxadiazole Derivatives App 20090197875 - Buettelmann; Bernd ; et al. | 2009-08-06 |
| Aryl-isoxazolo-4-yl-oxadiazole derivatives Grant 7,541,372 - Buettelmann , et al. June 2, 2 | 2009-06-02 |
| Dual Nk1/nk3 Receptor Antagonists App 20090137806 - Hoffmann; Torsten ; et al. | 2009-05-28 |
| Aryl-isoxazolo-4-yl-oxadiazole derivatives App 20070161686 - Buettelmann; Bernd ; et al. | 2007-07-12 |
| Serotonin transporter (SERT) inhibitors for the treatment of depression and anxiety App 20070129419 - Grundschober; Christophe ; et al. | 2007-06-07 |
| NK-1 receptor antagonists Grant 7,211,579 - Funk , et al. May 1, 2 | 2007-05-01 |
| NK-1 receptor antagonists App 20060217393 - Funk; Christoph ; et al. | 2006-09-28 |
| Dual NK1/NK3 receptor antagonists App 20050090533 - Hoffmann, Torsten ; et al. | 2005-04-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 